Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Accured Expenses (2016 - 2026)

Organogenesis Holdings has reported Change in Accured Expenses over the past 10 years, most recently at -$1.3 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 81.16% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached $158000.0, up 114.88%, while the annual FY2025 figure was $158000.0, 114.88% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$1.3 million at Organogenesis Holdings, down from $1.4 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $10.0 million in Q1 2024 and troughed at -$12.8 million in Q4 2021.
  • A 5-year average of -$936400.0 and a median of -$1.6 million in 2024 define the central range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 1310.8% in 2022 and fell as far as 2234.15% in 2022.
  • Year by year, Change in Accured Expenses stood at -$12.8 million in 2021, then skyrocketed by 39.29% to -$7.8 million in 2022, then fell by 3.84% to -$8.1 million in 2023, then increased by 14.14% to -$6.9 million in 2024, then skyrocketed by 81.16% to -$1.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ORGO at -$1.3 million in Q4 2025, $1.4 million in Q3 2025, and $8.0 million in Q2 2025.